home > events calendar > more about event

World Advanced Therapies and Regenerative Medicine Congress 2017


17-19 May 2017

In May 2017 the newly named World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.

The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals. 

Key topics include:

  •  The next generation of ATMPs
  •  Regulation, reimbursement & commercialisation for advanced therapies around the globe
  •  CRISPR & gene editing
  •  Stem cells as a tool for drug discovery
  •  What’s next for cell and gene therapy, new era of regenerative medicine?
  •  New paradigms in manufacture: gene therapy & viral vectors
  •  Clinical development of immunotherapy & cell therapy
  •  New frontiers in repair and replacement of diseased tissues & organs
  •  Product, process & manufacturing development of ATMPS

Key speakers include:

  •  William (Bill) Burns, Governor and Trustee, Wellcome Trust, Vice Chairman,Vestergaard; Trustee, Institute of Cancer Research, London; Vice Chairman,Mesoblast
  •  Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University
  •  Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation
  •  Sonia Quaratino, Global Clinical Program Leader,Novartis Institutes For BioMedical Research
  •  Sven Kili, Vice President & Head, Gene Therapy Development, GSK

Contact information:

Assistance with conference registration or further information:

Issa Mauthoor


Sponsorship and exhibition opportunities:

Erica Baeta 


Conference programme and speaking opportunities:

Jessica Robinson 


Marketing opportunities and press relations:

Katy Scrivener 


For more information, visit the website: 

Download the brochure here:


email Business Design Centre, London
Print this page
Send to a friend
Industry Events

DIA 2017 Annual Meeting

18-22 June 2017, Chicago, IL

Themed “Driving Insights to Action,” DIA 2017 will host 8,000+ professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries. DIA 2017 boasts more than 450 exhibiting companies, 10+ tracks, and 160+ sessions focused on regulatory science, translational medicine, patient engagement, and value and access. Follow DIA 2017 updates on Twitter using #DIA2017.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

News and Press Releases

Aptar Pharma Partners with Kali Care to Develop Real-Time Medication Management Technology

Aptar Pharma and Kali Care have announced that they entered into a partnership in order to address the challenge of monitoring adherence in ophthalmic clinical trials. The combination of Aptar Pharma’s ophthalmic device expertise, and Kali Care’s ground-breaking digital monitoring system for ophthalmic medications, is likely to have a significant impact in reducing the costs and complexity of ophthalmic clinical trials.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement